These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9038345)

  • 1. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.
    Jonkman MF; Scheffer H; Stulp R; Pas HH; Nijenhuis M; Heeres K; Owaribe K; Pulkkinen L; Uitto J
    Cell; 1997 Feb; 88(4):543-51. PubMed ID: 9038345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa.
    Pasmooij AM; Pas HH; Deviaene FC; Nijenhuis M; Jonkman MF
    Am J Hum Genet; 2005 Nov; 77(5):727-40. PubMed ID: 16252234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.
    van den Akker PC; Pasmooij AMG; Joenje H; Hofstra RMW; Te Meerman GJ; Jonkman MF
    PLoS One; 2018; 13(2):e0192994. PubMed ID: 29470523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.
    Pasmooij AM; Nijenhuis M; Brander R; Jonkman MF
    J Invest Dermatol; 2012 May; 132(5):1374-83. PubMed ID: 22318390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for a point mutation and a deletion located at splice acceptor sites in the LAMB3 gene leads to generalized atrophic benign epidermolysis bullosa.
    Takizawa Y; Hiraoka Y; Takahashi H; Ishiko A; Yasuraoka I; Hashimoto I; Aiso S; Nishikawa T; Shimizu H
    J Invest Dermatol; 2000 Aug; 115(2):312-6. PubMed ID: 10951252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
    Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
    J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
    Pasmooij AM; Garcia M; Escamez MJ; Nijenhuis AM; Azon A; Cuadrado-Corrales N; Jonkman MF; Del Rio M
    J Invest Dermatol; 2010 Oct; 130(10):2407-11. PubMed ID: 20574443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination.
    Kiritsi D; He Y; Pasmooij AM; Onder M; Happle R; Jonkman MF; Bruckner-Tuderman L; Has C
    J Clin Invest; 2012 May; 122(5):1742-6. PubMed ID: 22466645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
    Gostyński A; Pasmooij AM; Del Rio M; Diercks GF; Pas HH; Jonkman MF
    Exp Dermatol; 2014 Feb; 23(2):130-2. PubMed ID: 24330315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Back mutation mosaic: a new genetic principle].
    Happle R
    Hautarzt; 1997 Sep; 48(9):613-4. PubMed ID: 9410843
    [No Abstract]   [Full Text] [Related]  

  • 12. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
    Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.
    Darling TN; Yee C; Bauer JW; Hintner H; Yancey KB
    J Clin Invest; 1999 May; 103(10):1371-7. PubMed ID: 10330419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele.
    Darling TN; Koh BB; Bale SJ; Compton JG; Bauer JW; Hintner H; Yancey KB
    J Invest Dermatol; 1998 Feb; 110(2):170-3. PubMed ID: 9457914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa.
    Floeth M; Fiedorowicz J; Schäcke H; Hammami-Hausli N; Owaribe K; Trüeb RM; Bruckner-Tuderman L
    J Invest Dermatol; 1998 Sep; 111(3):528-33. PubMed ID: 9740252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revertant mosaicism in the skin.
    Lai-Cheong JE; McGrath JA
    G Ital Dermatol Venereol; 2013 Feb; 148(1):73-82. PubMed ID: 23407079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound heterozygosity for a nonsense mutation and a splice site mutation in the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa.
    Tamai K; Ishida-Yamamoto A; Matsuo S; Iizuka H; Hashimoto I; Christiano AM; Uitto J; McGrath JA
    Lab Invest; 1997 Feb; 76(2):209-17. PubMed ID: 9042157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa.
    Huber A; Yee C; Darling TN; Yancey KB
    Exp Dermatol; 2002 Feb; 11(1):75-81. PubMed ID: 11952829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural gene therapy in dystrophic epidermolysis bullosa.
    van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
    Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex.
    Smith FJ; Morley SM; McLean WH
    J Invest Dermatol; 2004 Jan; 122(1):73-7. PubMed ID: 14962092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.